Amyloid-β, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 28 11 2019
medline: 20 4 2021
entrez: 28 11 2019
Statut: ppublish

Résumé

Epidemiological studies suggest a relationship between posttraumatic stress disorder (PTSD) and dementia. This study assessed whether Alzheimer's disease (AD) imaging biomarkers were elevated in Vietnam veterans with PTSD. The study compared cognition, amyloid-β, tau, regional brain metabolism and volumes, and the effect of APOE in 83 veterans with and without PTSD defined by the Clinician-Administered PTSD Scale. The PTSD group had significantly lower education, predicted premorbid IQ, total intracranial volume, and Montreal Cognitive Assessment score compared with the controls. There was no difference between the two groups in the imaging or genetic biomarkers for AD. Our findings do not support an association between AD pathology and PTSD of up to 50 years duration. Measures to assess cognitive reserve, a factor that may delay the onset of dementia, were lower in the PTSD group compared with the controls and this may account for the previously observed higher incidence of dementia with PTSD.

Sections du résumé

BACKGROUND
Epidemiological studies suggest a relationship between posttraumatic stress disorder (PTSD) and dementia.
OBJECTIVE
This study assessed whether Alzheimer's disease (AD) imaging biomarkers were elevated in Vietnam veterans with PTSD.
METHODS
The study compared cognition, amyloid-β, tau, regional brain metabolism and volumes, and the effect of APOE in 83 veterans with and without PTSD defined by the Clinician-Administered PTSD Scale.
RESULTS
The PTSD group had significantly lower education, predicted premorbid IQ, total intracranial volume, and Montreal Cognitive Assessment score compared with the controls. There was no difference between the two groups in the imaging or genetic biomarkers for AD.
CONCLUSION
Our findings do not support an association between AD pathology and PTSD of up to 50 years duration. Measures to assess cognitive reserve, a factor that may delay the onset of dementia, were lower in the PTSD group compared with the controls and this may account for the previously observed higher incidence of dementia with PTSD.

Identifiants

pubmed: 31771068
pii: JAD190913
doi: 10.3233/JAD-190913
doi:

Substances chimiques

Amyloid beta-Peptides 0
Apolipoproteins E 0
MAPT protein, human 0
Radiopharmaceuticals 0
tau Proteins 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-173

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Alby Elias (A)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.
Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Tia Cummins (T)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.
Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.

Fiona Lamb (F)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.

Regan Tyrrell (R)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.

Vincent Dore (V)

Commonwealth Scientific and Industrial Research Organization (CSIRO), Australia.

Rob Williams (R)

Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.

Jeffrey V Rosenfeld (JV)

Department of Surgery, Monash University, VIC, Australia.
Department of Neurosurgery, Alfred Hospital, Melbourne, VIC, Australia.

Malcolm Hopwood (M)

Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Victor L Villemagne (VL)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.

Christopher C Rowe (CC)

Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH